Creative Medical Technology Holdings, Inc.
CELZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 0% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | – | 60% | 60% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -54,330% | -64,823.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -54,603.2% | -61,802.5% |
| EPS Diluted | -0.48 | -0.48 | -0.83 | -1.12 |
| % Growth | 0% | 42.2% | 25.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |